Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 hours agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
FDA expands Pfizer boosters for more teens as omicron surges
AOL· 7 days agoThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12. Boosters ...
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 hours agoCureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of...
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 18 hours ago“I felt like I was dying,” said Norkus. Two days following a booster dose of the Pfizer COVID-19...
Some 700,000 Brits To Get Free Covid-19 Booster Shots This Week
Forbes· 5 days agoVaccines significantly reduce the chances of hospitalization and death from Covid-19. Follow-up...
Amid syphilis surge, doctors call for more testing during pregnancy
Washington Post via Yahoo News· 7 days agoThe nation’s largest coalition of obstetricians issued an urgent warning Thursday calling on doctors...
The No. 1 Biotech Stock Just Launched Higher — Here's Why
Investor's Business Daily· 2 days agoThe company is establishing its line-up of drugs behind bread-and-butter med Ingrezza.
‘Longest-suffering’ Covid patient, 72, dies after infection lasted for 613 DAYS
The US Sun· 7 days agoA MAN in Amsterdam has died after suffering from Covid continuously for a record-breaking 613 days....
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 2 days agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT
MedPage Today· 7 days agoAdjuvant radiotherapy (RT) after radical prostatectomy did not improve outcomes in prostate cancer...